As of 2025-05-21, the Relative Valuation of NexgenRx Inc (NXG.V) is 0.22 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.30 CAD, the upside of NexgenRx Inc based on Relative Valuation is -26.8%.
The range of the Relative Valuation is 0.07 - 0.28 CAD.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 29.1x | 19.0x |
| Forward P/E multiples | 19.1x - 25.7x | 24.8x |
| Fair Price | 0.07 - 0.28 | 0.22 |
| Upside | -77.2% - -5.1% | -26.8% |
| Date | P/E |
| 2025-05-01 | 33.56 |
| 2025-04-30 | 34.14 |
| 2025-04-25 | 34.14 |
| 2025-04-21 | 34.14 |
| 2025-04-15 | 34.14 |
| 2025-04-14 | 34.14 |
| 2025-04-10 | 33.56 |
| 2025-04-08 | 33.56 |
| 2025-04-07 | 32.40 |
| 2025-04-02 | 28.93 |
| 2025-03-31 | 32.40 |
| 2025-03-28 | 31.25 |
| 2025-03-27 | 30.09 |
| 2025-03-21 | 30.09 |
| 2025-03-10 | 28.93 |
| 2025-03-04 | 28.93 |
| 2025-03-03 | 29.51 |
| 2025-02-28 | 30.67 |
| 2025-02-24 | 30.09 |
| 2025-02-14 | 31.25 |
| 2025-02-13 | 31.82 |
| 2025-02-12 | 31.82 |
| 2025-02-10 | 28.93 |